Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Zepzelca
Zepzelca
6 Drugs Approved Despite Failed Trials or Minimal Data
BioSpace
Mon, 10/9/23 - 11:10 am
Ipsen
Sohonos
Sarepta Therapeutics
Elevidys
Biogen
Qalsody
Eisai
Aduhelm
Jazz Pharma
PharmaMar
Zepzelca
Acadia Pharma
Nuplazid
FDA Keeps Jazz’s SCLC Treatment on the Market Despite Failed Confirmatory Trial
BioSpace
Thu, 10/27/22 - 08:14 pm
Jazz Pharmaceuticals
FDA
Zepzelca
small cell lung cancer
FDA explains why it won't pull Jazz's accelerated approval despite a failed confirmatory trial
Endpoints
Wed, 10/26/22 - 10:34 am
Jazz Pharmaceuticals
FDA
metastatic small cell lung cancer
lung cancer
Zepzelca
Jazz preps first solid tumor launch with Zepzelca's small cell lung cancer nod
Fierce Pharma
Mon, 06/22/20 - 08:37 pm
Jazz Pharmaceuticals
solid tumors
cancer
Zepzelca
drug launches
Jazz Pharma’s $1B bet pays off with accelerated lung cancer approval
Endpoints
Tue, 06/16/20 - 10:37 am
Jazz Pharma
PharmaMar
FDA
Zepzelca
lurbinectedin
small cell lung cancer